Author:
Stanger Livia,Holinstat Michael
Funder
American Heart Association
National Institutes of Health
NIGMS
Subject
Pharmacology (medical),Pharmacology
Reference172 articles.
1. First selective 12-LOX inhibitor, ML355, impairs thrombus formation and vessel occlusion in vivo with minimal effects on hemostasis;Adili;Arteriosclerosis, Thrombosis, and Vascular Biology,2017
2. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids;Adkins;The Journal of Nutritional Biochemistry,2010
3. Anti-inflammatory potential of alpha-linolenic acid mediated through selective COX inhibition: Computational and experimental data;Anand;Inflammation,2014
4. Structure and ligand based drug design strategies in the development of novel 5- LOX inhibitors;Aparoy;Current Medicinal Chemistry,2012
5. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1;Arita;Journal of Experimental Medicine,2005
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献